Mangoceuticals (MGRX) Cash & Equivalents (2023 - 2026)

Mangoceuticals (MGRX) has 4 years of Cash & Equivalents data on file, last reported at $174562.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents changed N/A year-over-year to $174562.0; the trailing twelve-month figure through Mar 2026 stood at $174562.0 (changed N/A YoY), and the FY2025 full-year result was $1.5 million, changed N/A from the prior year.
• Cash & Equivalents declined to $174562.0 in Q1 2026, from $1.5 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $1.5 million in Q4 2025 to a low of $15305.0 in Q1 2024.
• A 4-year average of $603802.8 and a median of $456784.0 in 2023 frame the typical range for Cash & Equivalents.